Onglyza approved in EU in combination with other diabetes drugs

10/5/2009 | Google

European regulators approved AstraZeneca and Bristol-Myers Squibb's diabetes medicine Onglyza as a combination treatment with metformin or two other standard drugs for Type 2 diabetes. The companies plan to roll out Onglyza in the EU by the end of the year.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Compliance Specialist
MJHS
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC
Regulatory Senior Managing/Principal Engineer/Scientist
Exponent
Menlo Park, CA
Director of Claims
Meridian Health Plan
Detroit, MI